Samsung in Talks to Buy Alzheimer's Drug Maker for $42 Billion: Report

Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).

from NDTV Gadgets - Latest https://ift.tt/3Jtfszt

Comments

Popular posts from this blog

Scientists Detect Rising Microplastics in Human Brains, Study Raises Concerns

Google Pixel 9a to Be Available at the Same Price Point as Its Predecessor: Report

Realme 14 Pro Series Global Launch Confirmed at MWC Barcelona; ‘Ultra’ Model Reportedly Teased